1.In Silico Structural and Functional Annotation of Hypothetical Proteins of Vibrio cholerae O139.
Md Saiful ISLAM ; Shah Md SHAHIK ; Md SOHEL ; Noman I A PATWARY ; Md Anayet HASAN
Genomics & Informatics 2015;13(2):53-59
In developing countries threat of cholera is a significant health concern whenever water purification and sewage disposal systems are inadequate. Vibrio cholerae is one of the responsible bacteria involved in cholera disease. The complete genome sequence of V. cholerae deciphers the presence of various genes and hypothetical proteins whose function are not yet understood. Hence analyzing and annotating the structure and function of hypothetical proteins is important for understanding the V. cholerae. V. cholerae O139 is the most common and pathogenic bacterial strain among various V. cholerae strains. In this study sequence of six hypothetical proteins of V. cholerae O139 has been annotated from NCBI. Various computational tools and databases have been used to determine domain family, protein-protein interaction, solubility of protein, ligand binding sites etc. The three dimensional structure of two proteins were modeled and their ligand binding sites were identified. We have found domains and families of only one protein. The analysis revealed that these proteins might have antibiotic resistance activity, DNA breaking-rejoining activity, integrase enzyme activity, restriction endonuclease, etc. Structural prediction of these proteins and detection of binding sites from this study would indicate a potential target aiding docking studies for therapeutic designing against cholera.
Bacteria
;
Binding Sites
;
Cholera
;
Computer Simulation*
;
Developing Countries
;
DNA
;
DNA Restriction Enzymes
;
Drug Discovery
;
Drug Resistance, Microbial
;
Genome
;
Humans
;
Integrases
;
Sewage
;
Solubility
;
Vibrio cholerae
;
Vibrio cholerae O139*
;
Water Purification
2.Mining the Proteome of Fusobacterium nucleatum subsp. nucleatum ATCC 25586 for Potential Therapeutics Discovery: An In Silico Approach.
Abdul Musaweer HABIB ; Md Saiful ISLAM ; Md SOHEL ; Md Habibul Hasan MAZUMDER ; Mohd Omar Faruk SIKDER ; Shah Md SHAHIK
Genomics & Informatics 2016;14(4):255-264
The plethora of genome sequence information of bacteria in recent times has ushered in many novel strategies for antibacterial drug discovery and facilitated medical science to take up the challenge of the increasing resistance of pathogenic bacteria to current antibiotics. In this study, we adopted subtractive genomics approach to analyze the whole genome sequence of the Fusobacterium nucleatum, a human oral pathogen having association with colorectal cancer. Our study divulged 1,499 proteins of F. nucleatum, which have no homolog's in human genome. These proteins were subjected to screening further by using the Database of Essential Genes (DEG) that resulted in the identification of 32 vitally important proteins for the bacterium. Subsequent analysis of the identified pivotal proteins, using the Kyoto Encyclopedia of Genes and Genomes (KEGG) Automated Annotation Server (KAAS) resulted in sorting 3 key enzymes of F. nucleatum that may be good candidates as potential drug targets, since they are unique for the bacterium and absent in humans. In addition, we have demonstrated the three dimensional structure of these three proteins. Finally, determination of ligand binding sites of the 2 key proteins as well as screening for functional inhibitors that best fitted with the ligands sites were conducted to discover effective novel therapeutic compounds against F. nucleatum.
Anti-Bacterial Agents
;
Bacteria
;
Binding Sites
;
Colonic Neoplasms
;
Colorectal Neoplasms
;
Computer Simulation*
;
Drug Delivery Systems
;
Drug Discovery
;
Fusobacterium nucleatum*
;
Fusobacterium*
;
Genes, Essential
;
Genome
;
Genome, Human
;
Genomics
;
Humans
;
Ligands
;
Mass Screening
;
Mining*
;
Proteome*
3.Screening of novel alkaloid inhibitors for vascular endothelial growth factor in cancer cells: an integrated computational approach
Shah Md. SHAHIK ; Asma SALAUDDIN ; Md. Shakhawat HOSSAIN ; Sajjad Hossain NOYON ; Abu Tayab MOIN ; Shagufta MIZAN ; Md. Thosif RAZA
Genomics & Informatics 2021;19(1):e6-
Vascular endothelial growth factor (VEGF) is expressed at elevated levels by most cancer cells, which can stimulate vascular endothelial cell growth, survival, proliferation as well as trigger angiogenesis modulated by VEGF and VEGFR (a tyrosine kinase receptor) signaling. The angiogenic effects of the VEGF family are thought to be primarily mediated through the interaction of VEGF with VEGFR-2. Targeting this signaling molecule and its receptor is a novel approach for blocking angiogenesis. In recent years virtual high throughput screening has emerged as a widely accepted powerful technique in the identification of novel and diverse leads. The high resolution X-ray structure of VEGF has paved the way to introduce new small molecular inhibitors by structure-based virtual screening. In this study using different alkaloid molecules as potential novel inhibitors of VEGF we proposed three alkaloid candidates for inhibiting VEGF and VEGFR mediated angiogenesis. As these three alkaloid compounds exhibited high scoring functions, which also highlights their high binding ability, it is evident that these alkaloids can be taken to further drug development pipelines for use as novel lead compounds to design new and effective drugs against cancer.
4.Screening of novel alkaloid inhibitors for vascular endothelial growth factor in cancer cells: an integrated computational approach
Shah Md. SHAHIK ; Asma SALAUDDIN ; Md. Shakhawat HOSSAIN ; Sajjad Hossain NOYON ; Abu Tayab MOIN ; Shagufta MIZAN ; Md. Thosif RAZA
Genomics & Informatics 2021;19(1):e6-
Vascular endothelial growth factor (VEGF) is expressed at elevated levels by most cancer cells, which can stimulate vascular endothelial cell growth, survival, proliferation as well as trigger angiogenesis modulated by VEGF and VEGFR (a tyrosine kinase receptor) signaling. The angiogenic effects of the VEGF family are thought to be primarily mediated through the interaction of VEGF with VEGFR-2. Targeting this signaling molecule and its receptor is a novel approach for blocking angiogenesis. In recent years virtual high throughput screening has emerged as a widely accepted powerful technique in the identification of novel and diverse leads. The high resolution X-ray structure of VEGF has paved the way to introduce new small molecular inhibitors by structure-based virtual screening. In this study using different alkaloid molecules as potential novel inhibitors of VEGF we proposed three alkaloid candidates for inhibiting VEGF and VEGFR mediated angiogenesis. As these three alkaloid compounds exhibited high scoring functions, which also highlights their high binding ability, it is evident that these alkaloids can be taken to further drug development pipelines for use as novel lead compounds to design new and effective drugs against cancer.